Interestingly, RRN3 and TAF1A also showed gene amplification in early breast cancer lesions, such as non-invasive ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH). This evidence concerns the gene RRN3 and ductal breast carcinoma in situ.